Prognostic Value of Pentraxin-3 Level in Patients with STEMI and Its Relationship with Heart Failure and Markers of Oxidative Stress

Table 4

PTX3 levels in selected groups of patients.

	PTX3 (ng/mL)	P value
Gender
Male	2.05 (0.49; 25.7)	0.031
Female	2.52 (0.53; 19.4)
Initial TIMI flow
0	2.28 (0.66; 36.0)	0.061
1	1.91 (0.58; 15.3)
2	1.67 (0.41; 31.7)
3	1.58 (0.53; 6.83)
Final TIMI flow
0 + 1	3.35 (1.96; 77.2)	0.067
2	2.71 (0.99; 36.0)
3	2.07 (0.49; 19.4)
Killip
I	1.97 (0.44; 8.53)	<0.001
II	2.80 (0.77; 31.7)
III + IV	14.5 (0.93; 125)
Acute heart failure
no	1.97 (0.44; 8.53)	<0.001
yes	4.04 (0.81; 45.1)
Acute kidney injury
no	2.10 (0.49; 15.1)	0.015
yes	3.83 (0.87; 77.2)
Diabetes mellitus
no	2.02 (0.49; 14.5)	0.003
yes	2.89 (0.63; 45.2)
Hypercholesterolemia
no	2.75 (0.82; 37.5)	0.021
yes	2.05 (0.49; 15.3)

Values are shown as median (the 5th; 95th percentiles).
^*P values from the Kruskal-Wallis test or maximum-likelihood test.
TIMI: thrombolysis in myocardial infarction; Killip: Killip classification of heart failure.